The Effects of Aerobics Training on Balance in Patients With Multiple Sclerosis (NIA)

October 17, 2011 updated by: Dr. Donovan Adendorf, Nelson Mandela Metropolitan University

The Effects of Neuromuscular Training on Balance in Patients With Multiple Sclerosis

Standing Balance, with and without blindfold, will be measured on patients with Multiple Sclerosis using a Biodex Balance Scale.

A Twelve week intervention with one non impact aerobics group and one control group will be performed.

Standing balance will then be retested on all subjects and the results will be statistically compared.

Study Overview

Detailed Description

Standing Balance will be tested in 4 phases:

  • On a firm surface eyes open
  • On a frim surface eyes blindfolded
  • On a foam surface eyes open
  • On a foam surface eyes blindfolded

The aerobics classes will be conducted by a NIA (Non Impact Aerobics) instructor and will be a combination of tai chi, slow movement dancing, stretching and modified yoga stretches.

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Early Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Gaylord, Michigan, United States, 49735
        • Recruiting
        • HealthZone Chiropractic Clinic
        • Contact:
        • Contact:
        • Principal Investigator:
          • Donovan Adendorf, DC

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients that were diagnosed by a neurologist with Relapsing Remitting Multiple Sclerosis.
  • EDSS scale between 1 and 6.
  • Patients that are able to travel to and from a 12 week program location.

Exclusion Criteria:

  • Patients that were diagnosed by a neurologist with primary or secondary progressive multiple sclerosis.
  • EDSS scale above 6

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Active non impact aerobics
This group will be performing a 12 week non impact aerobics program twice a week.
a 12 week, twice a week class in non impact aerobics
Other Names:
  • Dancing, NIA, MS
Active Comparator: Control group: Passive lecture series
The control group will also be measured for balance and then attend a 12 week lecture series with no exercise. They will then also be remeasured post lectures series
a 12 week, once a week for one hour lecture series with no exercise. Topics will cover symptom management in Multiple Sclerosis
Other Names:
  • Lifestyle lectures, symptom management

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Biodex Scale Balance score: Automated
Time Frame: Change: baseline and 12 weeks
A patient will step up to a Biodex Balance scale and will be instructed to try and maintain balance on the machine until it produces an automated outcome score for balance. This number is directly related to a fall risk score in patients with neurological compromise.
Change: baseline and 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pre and post intervention questionaire
Time Frame: Change: baseline and 12 weeks
A fifty question questionaire will be administered pre and post intervention. These questions will focus on mood changes, attitude changes and overall quality of life changes related to adding exercise in their daily living.
Change: baseline and 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Donovan Adendorf, DC, Nelson Mandela Metropole University, Department of Health Sciences
  • Study Director: Rosa DuRandt, PhD, Professor: Human Movement Sciences, NMMU-Port Elizabeth South Africa
  • Study Chair: Maryna Baard, PhD, Faculty of Helath Sciences-NMMU, Port Elizabeth South Africa

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2011

Primary Completion (Anticipated)

March 1, 2012

Study Completion (Anticipated)

June 1, 2012

Study Registration Dates

First Submitted

October 13, 2011

First Submitted That Met QC Criteria

October 17, 2011

First Posted (Estimate)

October 18, 2011

Study Record Updates

Last Update Posted (Estimate)

October 18, 2011

Last Update Submitted That Met QC Criteria

October 17, 2011

Last Verified

October 1, 2011

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Multiple Sclerosis, Relapsing-Remitting

Clinical Trials on Non Impact Aerobics

3
Subscribe